Kidney Cancer Doctors Worldwide

Prof. Sezer Sağlam is a leading expert in kidney cancer with over 27 years of specialized practice. He brings extensive experience from prestigious institutions.

• Professor in Medical Oncology since 2016
• Fellowship-trained at Istanbul University – one of Turkey's top medical schools
• Active member of ESMO and ASCO – key oncology associations
• Specializes in complex gastrointestinal oncology cases

Dr. Ayshe Okumush is a radiation oncologist at Private NeoLife Medical Center. She earned her MD from Karadeniz Technical University in 2003. She completed a residency in radiation oncology at Sisli Etfal Training and Research Hospital from 2006 to 2011.

She served as a specialist at Diyarbakir Uckuyular Training and Research Hospital from 2011 to 2013 and at Sisli Etfal from 2013 to 2016. She then worked at Yeni Yuzyil University Private Gaziosmanpasa Hospital from 2016 to 2026. She joined NeoLife in 2026.

Memberships: Turkish Society for Radiation Oncology (TROD) and the European Society for Radiotherapy and Oncology (ESTRO). Clinical focus: SRS, SRT, SBRT; VMAT, IMRT; radiotherapy for head and neck, lung, and brain tumors; SGRT, TBI, and 3D brachytherapy.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Dr. Antonio Alcaraz has performed over 500 successful urological surgeries, many using minimally invasive techniques, at Teknon Medical Center.

• 38 years of experience in urology and kidney transplantation
• Specializes in laparoscopic and robotic-assisted procedures, including Da Vinci system
• Heads the Department of Urology and kidney transplantation
• Member of American Urological Confederation and European Urological Society

Prof. Montorsi is a top Italian expert in urology, specializing in minimally invasive and robotic kidney cancer surgeries. He has performed over 8,000 urology & andrology procedures.

• Director of the Urological Research Institute at Vita-Salute San Raffaele University
• Recipient of the Hugh Hampton Young Award for urologic oncology
• Honorary fellowship from the Royal College of Surgeons of England
• Published over 1,000 scientific papers

Dr. Mehmet Salih Iyikesici is a medical oncologist. His work focuses on metabolically supported chemotherapy (MSCT), ketogenic diet–supported cancer care, hyperthermia, hyperbaric oxygen therapy, and insulin potentiation therapy. He emphasizes care for breast, pancreatic, and gastric cancers.

He is a Medical Oncology Specialist at Neolife Medical Center (2026–present). He previously served at Private Bahçelievler Medical Park (2013–2026), Medicana Beylikdüzü (2010–2013), Silivri Anadolu (2009–2010), Diyarbakır Training and Research (2008–2009), and Bursa Çekirge State (2006–2008). Earlier, he worked as an Internal Medicine Specialist (1997–2003). He was an Assistant Professor at Altınbaş University (2014–2026).

Training: Medical Oncology subspecialty, Marmara University (2003–2006). Internal Medicine, Istanbul Haydarpaşa Numune (1992–1996). Medicine, Uludağ University (1985–1990). Member, Medical Oncology Association (since 2004). His recent research (2019–2020) covers gastric, breast, pancreatic, and lung cancers. Topics include long‑term survival in metastatic pancreatic cancer and feasibility in metastatic non‑small cell lung cancer (NSCLC).

Dr. Amit Tirosh is the Head of the Neuroendocrine Tumors (NET) Service at Sheba Medical Center. He is an international authority on von Hippel–Lindau (VHL) disease and hereditary tumor syndromes. Dr. Tirosh contributed to global clinical guidelines for VHL management. He also leads the Endocrine Oncology Bioinformatics Lab at Sheba.

• Contributor to the international expert panel on VHL management guidelines.
• Authored over 40 peer-reviewed papers in journals like JAMA and Gastroentrology.
• Maintains research affiliations with the NIH and the Weizmann Institute.
• Performs specialized NET treatments, including Lutetium-177 therapy and PRRT.

Dr. Shira Felder leads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior radiation oncologist specializing in gynecologic and urologic cancers. She trained at the Princess Margaret Cancer Centre in Toronto. Dr. Felder focuses on delivering targeted radiation while preserving her patients' quality of life.

• Uses precision techniques including VMAT, IMRT, SBRT, and brachytherapy.
• Treats cervical, uterine, ovarian, and prostate cancers.
• Maintains membership in the European Society for Radiotherapy & Oncology.
• Works at Sheba Medical Center, ranked 7th globally by Newsweek.
• Conducts research on brachytherapy safety and cervical cancer survival.

Professor Dr. Sefik Igdem specializes in radiation oncology, with advanced expertise in treating kidney cancer using cutting-edge technologies.

• Board-certified in radiation oncology with decades of experience
• Uses Truebeam Stx and Halcyons technologies for precise treatment
• Professor at Demiroğlu Bilim University, training future oncologists
• Focuses on conformal treatments to minimize side effects

Dr. David Kuczer is a radiation oncologist at Amethyst Radiotherapy in Vienna. He specializes in precise cancer treatment for tumors of the prostate, breast, and brain. Dr. Kuczer presents every patient case to an interdisciplinary tumor board. This ensures each person receives a validated treatment plan from a team of experts.

• Uses the Elekta Versa HD linear accelerator for precise tumor targeting.
• Treats complex conditions including glioblastoma, lung cancer, and meningioma.
• Coordinates care within a clinic ranked among Newsweek's World's Best Hospitals 2026.
• Provides IMRT, VMAT, and stereotactic radiosurgery for high-accuracy radiation.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Dr. Serkan Keskin achieved 1st place nationally in his Medical Oncology board exam. He works with advanced treatments like immunotherapy at Memorial Şişli Hospital.

• Over 25 years of experience treating complex cancers
• Uses advanced techniques including targeted therapy and chemotherapy
• Holds membership in leading global societies like ASCO and ESMO
• Recognized with the Best Poster Award at a National Cancer Congress
• Completed his oncology subspecialty training at Istanbul University Institute of Oncology

Dr. Solak brings specialized training from Hacettepe University Cancer Institute and extensive experience with diverse cancers, including kidney cases at Hisar Hospital Intercontinental.

• Specialized in oncology at Istanbul Sisli Etfal Training and Research Hospital
• Fellowship at The University of Texas MD Anderson Cancer Center
• Expertise in gastrointestinal and urologic cancers
• Practices evidence-based protocols from top-tier training

Dr. Mehmet Akif Ozturk is a medical oncology specialist at Memorial Şişli Hospital in Istanbul. He currently serves as a faculty member at Üsküdar University. Dr. Ozturk previously held a faculty position at Marmara University Pendik Training and Research Hospital. He treats patients at a JCI-accredited facility known for its high organ transplant success rates.

• Specializes in clinical oncology for local and international patients.
• Practices at Memorial Şişli, the first hospital in Turkey to earn JCI accreditation.
• Serves as a medical oncology specialist in Istanbul since 2018.
• Held specialist roles at several major Turkish medical centers throughout his career.

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications and international recognition.

• Member of European Society of Medical Oncology (ESMO)
• Trained in Melanoma and Kidney Cancer Clinic at Mount Vernon Cancer Center
• Published co-author in 'Handbook of Advanced Cancer Care Treatment'
• Professor at Haliç University, Istanbul

Assoc. Prof. Dr. Heves Sürmeli is a specialist in Internal Medicine and Medical Oncology. She received her medical degree (M.D.) from Eskişehir Osmangazi University in 2004. She completed her Internal Medicine residency at Kartal Dr. Lütfi Kırdar Training and Research Hospital, Istanbul (2005–2010). She then completed subspecialty training in Medical Oncology at the same hospital (2014–2017).

At the same center, she served as a Medical Oncology Specialist (2017–2023). She then worked as Administrative and Clinical Director (2023–2026). Her clinical interests include breast, lung, gynecologic, gastrointestinal, and urologic cancers.

She has published many articles in international peer‑reviewed journals. She has presented at national and international conferences. She is active in professional societies. She has received several awards.

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.